Healthcare Services

Viral Vector Affinity Resin Market Evolving Due to Rising Demand for Gene-Based Therapeutics and Purification Efficiency

April 28, 2026April 28, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, What Market Size Is The Viral Vector Affinity Resin Market Expected To Reach Based On Its 2026 Value?

The viral vector affinity resin market has experienced rapid expansion in recent years. This market is projected to expand from $0.62 billion in 2025 to $0.72 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 16.2%. Historically, this growth was driven by factors such as the expansion of viral vector research activities, the growing application of chromatography in bioprocessing, the proliferation of gene therapy development programs, an increasing need for scalable purification solutions, and advancements in resin manufacturing technologies.

The viral vector affinity resin market size is anticipated to experience rapid expansion in the coming years. It is projected to grow to $1.3 billion by 2030, achieving a compound annual growth rate (CAGR) of 15.9%. This growth over the forecast period can be attributed to the increasing commercialization of gene therapies, a rising demand for high-throughput purification platforms, the expansion of vaccine development pipelines, a growing emphasis on cost-efficient downstream processing, and the increasing adoption of customized affinity resins. Major trends expected during the forecast period include the increasing adoption of high-capacity affinity resins, a rising demand for AAV and lentiviral purification solutions, the growing use of single-use chromatography systems, the expansion of ligand-specific resin development, and an enhanced focus on high-purity viral vector processing.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30426&type=smp

Which Key Factors Are Driving The Viral Vector Affinity Resin Market Growth?

The expanding use of gene-based therapeutics is projected to stimulate expansion in the viral vector affinity resin market in the foreseeable future. These cutting-edge treatments involve employing DNA, RNA, or viral vectors to alter or manage gene expression inside a patient’s cells. The increasing acceptance of gene-based therapies stems from improvements in delivery technologies, which allow for the secure, effective, and precise delivery of genetic material into cells. Viral vector affinity resin supports the broader embrace of gene-based therapeutics by offering highly pure, scalable purification methods, which are crucial for viral vector production. These resins mitigate obstacles in downstream processing through their ability to effectively separate viral vectors from contaminants, thereby boosting production efficiency and facilitating wider clinical and commercial uses. For instance, in December 2024, according to the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, the Food and Drug Administration (FDA) approved six gene therapy products in 2023, up from five approvals in 2022. Consequently, the growing integration of gene-based therapeutics is fostering the expansion of the viral vector affinity resin market.

Which Segment Types Are Examined In The Viral Vector Affinity Resin Market Segment Study?

The viral vector affinity resin market covered in this report is segmented –

1) By Product Type: Adenoviral Vector Affinity Resin, Lentiviral Vector Affinity Resin, Adeno-Associated Viral (AAV) Vector Affinity Resin, Retroviral Vector Affinity Resin, Other Product Types

2) By Application: Gene Therapy, Vaccine Development, Cell Therapy, Other Applications

3) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations

Subsegments:

1) By Adenoviral Vector Affinity Resin: Cell Lysis-Based Adenoviral Vector Affinity Resin, Chromatography-Based Adenoviral Vector Affinity Resin, High-Capacity Adenoviral Vector Affinity Resin, Prepacked Column Adenoviral Vector Affinity Resin

2) By Lentiviral Vector Affinity Resin: High-Purity Lentiviral Vector Affinity Resin, Column-Based Lentiviral Vector Affinity Resin, Membrane Chromatography Lentiviral Vector Affinity Resin, Single-Use Lentiviral Vector Affinity Resin

3) By Adeno-Associated Viral Vector Affinity Resin: Serotype-Specific Adeno-Associated Viral Vector Affinity Resin, High-Capacity Adeno-Associated Viral Vector Affinity Resin, Prepacked Column Adeno-Associated Viral Vector Affinity Resin, Ligand-Based Adeno-Associated Viral Vector Affinity Resin

4) By Retroviral Vector Affinity Resin: High-Selectivity Retroviral Vector Affinity Resin, Column-Based Retroviral Vector Affinity Resin, Membrane-Based Retroviral Vector Affinity Resin, Prepacked Retroviral Vector Affinity Resin

5) By Other Product Types: Hybrid Viral Vector Affinity Resin, Multimodal Viral Vector Affinity Resin, Recombinant Ligand Affinity Resin, Customized Viral Vector Affinity Resin

Which Players Are Part Of The Competitive Landscape Of The Viral Vector Affinity Resin Market?

Major companies operating in the viral vector affinity resin market are Thermo Fisher Scientific, GE Healthcare Technologies Inc., Repligen Corporation, Creative Biolabs, JNC Corporation, Aptamer Group, ChromaGenix Inc., Cytiva (Danaher Corporation), Merck KGaA, Sartorius AG, Purolite Life Sciences, Tosoh Bioscience, Bio-Rad Laboratories, Avantor Inc., Pall Corporation, Takara Bio Inc., Cube Biotech, Agilent Technologies, Promega Corporation, Kaneka Corporation

Get The Full Viral Vector Affinity Resin Market Report:

https://www.thebusinessresearchcompany.com/report/global-viral-vector-affinity-resin-market-report

Which Region Has The Greatest Market Share In The Viral Vector Affinity Resin Market?

North America was the largest region in the viral vector affinity resin market in 2025. The regions covered in the viral vector affinity resin market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Viral Vector Affinity Resin Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/global-viral-vector-affinity-resin-market-report

Browse Through More Reports Similar to the Global Viral Vector Affinity Resin Market 2026, By The Business Research Company

Oral Expectorant Market Report 2026

https://www.thebusinessresearchcompany.com/report/oral-expectorant-global-market-report

Viral And Non Viral Vector Manufacturing Market Report

https://www.thebusinessresearchcompany.com/report/viral-and-non-viral-vector-manufacturing-global-market-report

Protein A Resin Market Report

https://www.thebusinessresearchcompany.com/report/protein-a-resin-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795